PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-20

  1. 3,172 Posts.
    lightbulb Created with Sketch. 558
    Excerpt from the last report -

    “Our primary focus over the past three months or so has been to secure one or more new pipeline assets that we can bring into the company,” commented Percheron CEO, Dr James Garner. “We have a number of promising leads under discussion, and we are highly optimistic that we will be in a position to re-launch the company mid-year with a new story and as a compelling new opportunity for investors. In the meantime, our discussions and negotiations continue, and we will endeavour to provide as much information as we can to investors as matters progress.”

    Well, mid-year is here and we are still in the dark, so J.G. had better come up with something soon or investors will start to get restless and maybe another challenge could be on the cards?? - Let's have some newsflow to calm the nerves!

    GLTAH
    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $9.786M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $94.66K 10.09M

Buyers (Bids)

No. Vol. Price($)
4 661860 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1588275 6
View Market Depth
Last trade - 15.52pm 27/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.